✦ LIBER ✦

Pharmacokinetic and Pharmacodynamic Profile of Empagliflozin, a Sodium Glucose Co-Transporter

✍ Scribed by Scheen, André J.

Book ID: 121550250
Publisher: Springer International Publishing AG
Year: 2014
Tongue: English
Weight: 430 KB
Volume: 53
Category: Article
ISSN: 0312-5963
DOI: 10.1007/s40262-013-0126-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Pharmacokinetics and Pharmacody

Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2

✍ Kasichayanula, Sreeneeranj; Liu, Xiaoni; LaCreta, Frank; Griffen, Steven C.; Bou 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 522 KB

Empagliflozin, a sodium glucose co-trans

Empagliflozin, a sodium glucose co-transporter 2 inhibitor, in the treatment of type 1 diabetes

✍ Lamos, Elizabeth M; Younk, Lisa M; Davis, Stephen N 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 308 KB

Pharmacokinetics, pharmacodynamics and s

Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairment

✍ Macha, S.; Mattheus, M.; Halabi, A.; Pinnetti, S.; Woerle, H. J.; Broedl, U. C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 598 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus

✍ Devineni, Damayanthi; Curtin, Christopher R.; Polidori, David; Gutierrez, Maria 📂 Article 📅 2013 🏛 Sage Publications 🌐 English ⚖ 605 KB

Effects of Hydrochlorothiazide on the Ph

Effects of Hydrochlorothiazide on the Pharmacokinetics, Pharmacodynamics, and Tolerability of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor, in Healthy Participants

✍ Devineni, Damayanthi; Vaccaro, Nicole; Polidori, David; Rusch, Sarah; Wajs, Ewa 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 437 KB

Safety, Pharmacokinetic, and Pharmacodyn

Safety, Pharmacokinetic, and Pharmacodynamic Profiles of Ipragliflozin (ASP1941), a Novel and Selective Inhibitor of Sodium-Dependent Glucose Co-Transporter 2, in Patients with Type 2 Diabetes Mellitus

✍ Schwartz, Sherwyn L.; Akinlade, Bola; Klasen, Sally; Kowalski, Donna; Zhang, Wen 📂 Article 📅 2011 🏛 Mary Ann Liebert 🌐 English ⚖ 322 KB